Ozempic, Wegovy Improve Blood Sugar Control and Weight Loss Over 3 Years, Study Finds
Semaglutide, a GLP-1 receptor agonist, improves blood sugar control and promotes weight loss in type 2 diabetes patients over three years. FDA-approved Wegovy for obesity, it's also used off-label for weight loss. Effective in real-world settings, it requires long-term use and professional monitoring, with potential side effects.
Reference News
Ozempic, Wegovy Improve Blood Sugar Control and Weight Loss Over 3 Years, Study Finds
Semaglutide, a GLP-1 receptor agonist, improves blood sugar control and promotes weight loss in type 2 diabetes patients over three years. FDA-approved Wegovy for obesity, it's also used off-label for weight loss. Effective in real-world settings, it requires long-term use and professional monitoring, with potential side effects.